Informations générales (source: ClinicalTrials.gov)
Assessments and Recommendations for the Implementation of Advance Directives in Oncology (DA)
Interventional
N/A
Assistance Publique Hopitaux De Marseille (Voir sur ClinicalTrials)
décembre 2015
décembre 2017
29 juin 2024
Legitimized by the Leonetti law of April 22, 2005, advance directives (AD) appear in
various places of care that alongside the end of life, and even tend to be generalized to
all areas related to health care in general. In this context, a prospective study to
assess how the patient will seize the AD and identify the different problems writing
these AD will be conducted. From this study, it will establish recommendations for the
implementation of AD in the Multidisciplinary Oncology Department and Therapeutic
Innovations service and in oncology in general. They will be asked patients if they
choose to write their AD, complete and sign the AD pre-written in the book or not to
draft their AD. The choice of the patients, but also the reasons they associate thereto
and, where appropriate, their AD written will be collected. The patient will also inform
its demographic and socio the case report (clinical data) should be completed by the
investigator. During the first part of research, the use of AD by patients and will be
assessed and analyzed in connection with the characteristics of these patients (history
of the disease, course of care, socio-demographic) and the reasons they set out to
explain their choice. For those who write their AD, they will, in a second step, subject
to thematic content analysis to identify the main aspects that the subject convened to
consider its end of life.This research therefore lead to the definition of the contours
of a user device AD in oncology in general. This study was qualified biomedical research
because of the sensitive nature of the study population and bring the patient to personal
preoccupations when filling the questionnaire on the choice of directing advance
directives and their contents.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Assistance Publique Hôpitaux de Marseille - 13354 - Marseille - France | DESALBRES Urielle, Director | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Subject both sexes
- Subject whose age is between 18 and 85 years
- Subject with cancer
- Subjects for which French is the native language, about having read, understood and
signed the informed consent
- Subject both sexes
- Subject whose age is between 18 and 85 years
- Subject with cancer
- Subjects for which French is the native language, about having read, understood and
signed the informed consent
- Subject minors or subjects aged over 85 years
- Subject not including the French
- Subject with neurological or psychiatric disorders prohibiting their understanding
of the study
- Subject private freedom following a judicial or administrative decision